Caris ChromoSeq
Whole-genome/transcriptome profiling for diagnosed or suspected myeloid malignancies.
- Developer
- Caris Life Sciences
- Intended use
- Diagnostic Aid
- Cancer scope
- Not reported
- Specimen
- Bone marrow aspirate, Peripheral whole blood
- Molecular modality
- DNA mutation, RNA
- Current version
- Current Caris ChromoSeq
- Evidence context
- 1 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.